news
July 1 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
June 27 2019
Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Initiates Second Pruritus Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™
June 24 2019
BioEclipse Therapeutics™ Announces Appointment of New Directors and Series A-1 Financing
 |
|
events
Aug 7-8 2019
Canaccord Genuity 39th Annual Growth Conference
Aug 13-14 2019
Wedbush Pacgrow Healthcare Conference
Sept 3-4 2019
PAIN Week
Sept 4-5
RW Baird Healthcare Conference
|
|
spotlight
|
